Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

DuPont describes new HIV protease inhibitors

Jan. 20, 1999

Antiidiotype MAb in development by Immune Network Research receives patent coverage

Jan. 19, 1999

Epitope-based HIV vaccines show promise according to results from studies in primates

Jan. 18, 1999

Provir to be provided to certain AIDS patients in open-label trial

Jan. 14, 1999

Adoptive immunotherapy for HIV infection shows potential in phase I study

Jan. 8, 1999

Favorable preclinical, clinical results continue to encourage development of ABT-378

Jan. 7, 1999

More anti-HIV, antimalarial agents available for licensing from NIH

Jan. 7, 1999

Combinations of K-12 and other anti-HIV compounds tested in vitro for synergy

Jan. 7, 1999

Therapies that improve thymus function for immune reconstitution following HAART

Jan. 5, 1999

New HIV protease inhibitor JE-2147 with promising preclinical profile

Jan. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...